Search results
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 6 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
UK researchers trial monitoring technology for patients with rheumatoid arthritis
Hospital Management via Yahoo Finance· 5 days ago"UK researchers trial monitoring technology for patients with rheumatoid arthritis" was originally...
Polyarthritis vs. oligoarthritis: Symptoms, causes, and more
Medical News Today· 3 days ago“Polyarthritis” and “oligoarthritis” describe the number of joints involved in arthritic conditions,...
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 6 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
Sjogren's Syndrome
Health· 5 days agoTreatments like eye drops and medications can help decrease symptoms, although some may still be bothersome. It’s also important to...Sjogren’s Syndrome...
REMORA: New technology is first to allow patients to add daily symptoms to their health record
Medical Xpress· 5 days agoThe Remote Monitoring of Rheumatoid Arthritis (REMORA) system allows patients to download a symptom...
Amgen Inc. (NASDAQ:AMGN) Stake Lowered by First PREMIER Bank
ETF DAILY NEWS· 6 hours agoFirst PREMIER Bank reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.1% during the 1st quarter, according to the company in its most recent filing with the Securities ...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 5 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of...
Use This Common Cardiac Test in RA Patients, Study Suggests
MedPage Today· 6 days agoPatients with rheumatoid arthritis (RA) are likely to benefit from regular high-sensitivity cardiac...
TD Cowen keeps 'Buy' on AnaptysBio stock, cites potential of rosnilimab in RA By Investing.com
Investing.com· 3 days agoDespite the decision not to continue developing the drug for alopecia areata, its progression in...